About Medical Devices and Pharma

Industry and consumer-oriented medical device and pharmaceutical information

About Us

Medical Devices and Pharma LLC is a professional provider of expert regulatory consulting services for manufacturers of medical devices and pharmaceutical products regulated by the United States Food and Drug Administration (FDA), Health Canada, the European Union (EU), and globally.

This webpage not only provides regulatory information and assistance, but it is also a consumer-oriented resource designed to present timely safety news, helpful information, and analysis for users of medical devices and pharmaceutical products.

Our Mission

The mission of Medical Devices and Pharma is to provide the highest quality personalized professional regulatory services to our clients.

We maintain vigilance and provide timely safety information to consumers of medical device and pharmaceutical products, and provide insight and guidance to companies in FDA-regulated industries regarding their products, processes, innovation, product safety, and enforcement.

Who We Serve

We proudly support:

  • Medical Device Manufacturers seeking compliance with QMSR and ISO 13485
  • Startups and SMEs navigating FDA regulatory requirements for the first time
  • Regulatory and Quality Professionals looking to expand their expertise
  • Educational Institutions preparing the next generation of regulatory experts

Regulatory and Quality Information at Your Fingertips

We designed the Medical Devices and Pharma website to present critical industry information in a well-organized and easy-to-navigate format. We stay up-to-date with regulatory agency announcements and activities, so visitors to the site will see current information about medical devices, pharmaceuticals, biologics, combination products, and other regulated medical products.

Contact us

We are available to respond to regulatory questions, strategies, or managed projects. Do you have regulatory questions about your medical device or pharmaceutical product? Let us know – please contact us and we can provide regulatory guidance and advice for upcoming regulatory projects.

Sphygmomanometer

Regulatory and Quality Headlines

QSR-to-QMSR Paper Gap Audit

Is Your Quality Management System Ready for QMSR? As FDA’s transition from the QSR to the QMSR approaches, many medical device manufacturers are discovering that “substantially equivalent” doesn’t mean “completely aligned.” Even companies with solid QSR documentation...

read more

Postmarket Surveillance – from QSR to QMSR

How QSR Postmarket Surveillance Will Evolve Under the QMSR  As medical device manufacturers transition from the FDA’s Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR), one area undergoing significant change is postmarket...

read more

Postmarket Surveillance

What is Postmarket Surveillance (PMS)? Postmarket surveillance (PMS) refers to all activities carried out by manufacturers to monitor the performance, safety, and effectiveness of a medical device after it has been placed on the market. It includes collecting and...

read more

Medical Device Labeling

In the world of medical devices, proper labeling isn't just a regulatory requirement, it is a vital component of patient safety, product usability, and market access. Whether you're a manufacturer navigating FDA regulations, a distributor handling multilingual...

read more

QMSR Clause 8 – Measurement Analysis and Improvement

ISO 13485 Clause 8 Transition Notes  The QMSR eliminates FDA-specific structure in favor of ISO 13485:2016 clauses. All above ISO 13485 clauses are now explicit requirements under QMSR.  New documentation and risk-based decision-making are emphasized throughout the...

read more

QMSR Clause 7 – Product Realization

ISO 13485 Clause 7 - Product Realization  Clause 7 of ISO 13485, titled Product Realization, outlines the structured approach medical device manufacturers must take to design, develop, produce, and deliver devices that meet customer needs and regulatory requirements....

read more

QMSR Clause 6 – Resource Management

ISO 13485 Clause 6 - Resource Management  Like other QSR-to-QMSR transition themes, there is a close alignment between 21 CFR 820.20(b), 820.25, and 820.70 ISO 13485 Clause 6 in their subjects of resources, personnel, training and documentation, awareness of work...

read more

The Role of a Regulatory Professional

510(k) Submissions The New QSMR Regulatory Intelligence RIM Systems Regulatory Competencies Regulatory and Quality Role of Regulatory Professionals: Core Responsibilities Regulatory professionals play a critical role in ensuring that medical devices and pharmaceutical...

read more

Urgent Recall: Dr. Reddy’s Levetiracetam Injection

What You Need to Know Dr. Reddy’s Laboratories has issued an urgent recall for one batch (Lot No: A1540076) of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL due to a serious labeling error. The infusion bag is incorrectly labeled as Levetiracetam...

read more

FDA Issues Warning on Epinephrine Nasal Solutions

Left: BPI Labs’ FDA-approved Epinephrine Injection with blue lid on the bottle.Right: BPI Labs’ unapproved EPINEPHrine Chloride Nasal Solution with red lid on the bottle.Courtesy: FDA.A Potentially Dangerous Mix-Up The U.S. Food and Drug Administration (FDA) has...

read more